HKUST 2011 iGEM Team E. trojan Boosting the effectiveness of - - PowerPoint PPT Presentation

hkust 2011 igem team
SMART_READER_LITE
LIVE PREVIEW

HKUST 2011 iGEM Team E. trojan Boosting the effectiveness of - - PowerPoint PPT Presentation

HKUST 2011 iGEM Team E. trojan Boosting the effectiveness of antibiotics through quorum- sensing disruption INTRODUCTION Mistakes Penicillin G Amikacin, Gentamicin, Kanamycin, Neomycin, Netilmicin, Tobramycin, Paromomycin, Loracarbef,


slide-1
SLIDE 1

HKUST 2011 iGEM Team

  • E. trojan – Boosting the effectiveness
  • f antibiotics through quorum-

sensing disruption

slide-2
SLIDE 2

INTRODUCTION

slide-3
SLIDE 3

Mistakes…

Penicillin G

slide-4
SLIDE 4

Amikacin, Gentamicin, Kanamycin, Neomycin, Netilmicin, Tobramycin, Paromomycin, Loracarbef, Ertapenem, Doripenem, Imipenem, Meropenem, Cefadroxil, Cefazolin, Cefalotin, Cefalexin, Cefaclor, Cefamandole, Cefoxitin, Cefprozil, Cefuroxime, Cefixime, Cefdinir, Cefditoren, Cefoperazone, Cefotaxime, Cefpodoxime, Ceftazidime, Ceftibuten, Ceftizoxime, Ceftriaxone, Cefepime, Ceftobiprole, Teicoplanin, Vancomycin, Telavancin, Clindamycin, Lincomycin, Daptomycin, Azithromycin, Clarithromycin, Dirithromycin, Erythromycin, Roxithromycin, Troleandomycin, Telithromycin, Spectinomycin, Aztreonam, Furazolidone, Nitrofurantoin, Amoxicillin, Ampicillin, Azlocillin, Carbenicillin, Cloxacillin, Dicloxacillin, Flucloxacillin, Mezlocillin, Methicillin, Nafcillin, Oxacillin, Penicillin, Piperacillin, Temocillin, Ticarcillin, Bacitracin, Colistin, Polymyxin B …

slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7

Charity

slide-8
SLIDE 8

Indole Signalling Disruption (T4MO) Antibiotic-Free Selection

  • E. TROJAN

Reduce Antibiotic Usage Rearm Antibiotics

slide-9
SLIDE 9
  • E. CRAFT – AN ALTERNATIVE

TRANSFORMATION METHOD

slide-10
SLIDE 10

Essential- gene- based selection method:

  • E. CRAFT

Eschericia coli Re-engineered for Antibiotic- Free Transformation

Deletion of an essential gene from E. CRAFT’s genome  Addiction to extragenomic source of the gene

slide-11
SLIDE 11

pCarrier,

a heat- insensitive analog of pDummy

TRANSFORMATION TRANSFORMATION

slide-12
SLIDE 12

The selection, comparison between successful and unsuccessful transformation

PLASMID SHUFFLING

slide-13
SLIDE 13

Development of addiction: use of the phage λ RED Recombination System

Phage λ RED Recombinase circumvents host’s internal barriers against

  • recombination. Presence of homologous sequences allows complementation
  • f the 3’ overhangs of the Foreign dsDNA to the host gDNA, making possible a

swap between the two DNA sequences.

Essential Gene

slide-14
SLIDE 14

How to keep the plasmid with no resistance? Mutualistic Plasmids

Essential Gene

slide-15
SLIDE 15

How to keep the plasmid with no resistance? Mutualistic Plasmids

ANTIBIOTIC RESISTANT GENE

slide-16
SLIDE 16

How to keep the plasmid with no resistance? Mutualistic Plasmids

Essential Gene

ANTIBIOTIC RESISTANT GENE

slide-17
SLIDE 17

Use of split reporter system as indicator of completion of E. CRAFT construction

slide-18
SLIDE 18

The E. trojan

  • E. CRAFT + pCarrier with T4MO
slide-19
SLIDE 19

CHARACTERIZATION OF BIOBRICK BBa_K524000

slide-20
SLIDE 20

BioBrick Characterization – BBa_K524000 Heat Sensitive Origin oriR101 & repA101-ts

Properties:

  • Derivative of pSC101 origin
  • oriR101 positively regulated by a heat liable

protein of gene repA101-ts

  • Stops replication at 420C #

# Phillips GJ.(1995). New Cloning Vectors with Temperature-Sensitive Replication,

  • Plasmid. 1999 Jan;41(1):78-81.
slide-21
SLIDE 21

BioBrick Characterization – BBa_K524000 Heat Sensitive Origin oriR101 & repA101-ts

slide-22
SLIDE 22

BioBrick Characterization – BBa_K524000 Heat Sensitive Origin oriR101 & repA101-ts

FULL DILUTION DISPLAY

slide-23
SLIDE 23

CULTURE TEST RESULTS

slide-24
SLIDE 24

RR-1

0 μg/ml 25 μg/ml kanamycin gradient

slide-25
SLIDE 25

RR-1

0 μg/ml kanamycin gradient with 25 μg/ml indole

(300nM/1mM)

slide-26
SLIDE 26
  • 0.4
  • 0.2

0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 2 4 6 8 10 12 14 16

OD600 Kanamycin concentration (µg/ml)

Comparison of MICs for indole and non-indole supplemented RR1

RR1 w/ 1mM indole RR1 RR1 w/ 300μM indole

slide-27
SLIDE 27

RR-1

RFP/ KanR 0 μg/ml kanamycin gradient 25 μg/ml

slide-28
SLIDE 28

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 5 7 8 10 12 14 16 18 20 25

Ratio Kanamycin concentration (µg/ml)

Ratio of RR1 to RFP in Mixed MIC

RR1 RFP

slide-29
SLIDE 29

RR-1

T4MO/ GFP/ KanR

0 μg/ml kanamycin gradient 25 μg/ml

slide-30
SLIDE 30

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 5 7 8 10 12 14 16 18 20 25

Ratio Kanamycin concentration (µg/ml)

Ratio of RR1 to RFP in Mixed MIC

RR1 RFP

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 5 7 8 10 12 14 16 18 20 25

Ratio Kanamycin concentration (µg/ml)

Ratio of RR1 to T4MO in Mixed MIC

RR1 T4MO

slide-31
SLIDE 31
  • 1

1 2 3 4 5 5 10 15 20 25 30 35

Ratio Kanamycin concentration (µg/ml) Comparison of RFP and T4MO on Charity work

T4MO:RR1 RFP:RR1

slide-32
SLIDE 32
  • E. trojan
  • Basis for future

model on other pathogenic species which also apply indole charity

slide-33
SLIDE 33

HUMAN PRACTICE

slide-34
SLIDE 34
  • HKUST Synthetic

Biology Workshop 2011

  • Synthetic Biology

Survey

slide-35
SLIDE 35

Workshop (17th Sept 2011)

1) Introductory talk on Synthetic Biology 2) “The Life of E. coli”

  • An educational

card game 3) Laboratory tour 4) Creative design for Synthetic Biology

slide-36
SLIDE 36

Take genes from the electric eel and put it into a mouse…

Creative Design

Pikachu?!

slide-37
SLIDE 37

Synthetic Biology Survey

  • A collaboration with

IDC and Biofaction

  • Online format
  • 570 responses as of

1st Oct 2011

slide-38
SLIDE 38

This is just the beginning…

HKUST Synthetic Biology Workshop Synthetic Biology Survey

slide-39
SLIDE 39

CONCLUSION

slide-40
SLIDE 40

Conclusion

Indole Signalling Disruption (T4MO) Antibiotic-Free Selection

  • E. TROJAN

Reduce Antibiotic Usage Rearm Antibiotics

Your Target?

  • S. aureus?

Klebsiella? Salmonella?

  • P. aeruginosa?
slide-41
SLIDE 41

Acknowledgements

  • IDC - Organisation for International Dialogue and Conflict Management
  • Biofaction
  • The Hong Kong Institute of Engineers (HKIE)
  • The Hong Kong Teachers’ Association (HKTA)
  • Dr Markus SCHMIDT and Dr Lei PEI
  • The Provost's Office, HKUST
  • Division of Biomedical Engineering, HKUST
  • Division of Life science, HKUST
  • Department of Social Science, HKUST
  • Prof. King L. CHOW, Dr Jessica Ce Mun TANG, Prof. Michelle YIK and Mr Jin ZENG
  • The Coli Genetic Stock Center
  • Mr. Kevin McClay, Cornell University
  • iGEM 2011 CUHK team
  • Life Technology, Inc.
  • And many others not mentioned.
slide-42
SLIDE 42

Q&A SECTION